Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
- PMID: 10516307
- PMCID: PMC6782787
- DOI: 10.1523/JNEUROSCI.19-20-08876.1999
Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is thought to be caused in part by the age-related accumulation of amyloid beta-protein (Abeta). The presence of neuritic plaques containing abundant Abeta-derived amyloid fibrils in AD brain tissue supports the concept that fibril accumulation per se underlies neuronal dysfunction in AD. Recent observations have begun to challenge this assumption by suggesting that earlier Abeta assemblies formed during the process of fibrillogenesis may also play a role in AD pathogenesis. Here, we present the novel finding that protofibrils (PF), metastable intermediates in amyloid fibril formation, can alter the electrical activity of neurons and cause neuronal loss. Both low molecular weight Abeta (LMW Abeta) and PF reproducibly induced toxicity in mixed brain cultures in a time- and concentration-dependent manner. No increase in fibril formation during the course of the experiments was observed by either Congo red binding or electron microscopy, suggesting that the neurotoxicity of LMW Abeta and PF cannot be explained by conversion to fibrils. Importantly, protofibrils, but not LMW Abeta, produced a rapid increase in EPSPs, action potentials, and membrane depolarizations. These data suggest that PF have inherent biological activity similar to that of mature fibrils. Our results raise the possibility that the preclinical and early clinical progression of AD is driven in part by the accumulation of specific Abeta assembly intermediates formed during the process of fibrillogenesis.
Figures
Similar articles
-
Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.Neuropharmacology. 2012 Feb;62(2):871-81. doi: 10.1016/j.neuropharm.2011.09.016. Epub 2011 Sep 24. Neuropharmacology. 2012. PMID: 21958557
-
Neuronal fibrillogenesis: amyloid fibrils from primary neuronal cultures impair long-term memory in the crab Chasmagnathus.Behav Brain Res. 2003 Dec 17;147(1-2):73-82. doi: 10.1016/s0166-4328(03)00118-9. Behav Brain Res. 2003. PMID: 14659572
-
Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils.J Neurosci. 2010 Oct 27;30(43):14411-9. doi: 10.1523/JNEUROSCI.3537-10.2010. J Neurosci. 2010. PMID: 20980598 Free PMC article.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Amyloid fibril toxicity in Alzheimer's disease and diabetes.Ann N Y Acad Sci. 1996 Jan 17;777:89-95. doi: 10.1111/j.1749-6632.1996.tb34406.x. Ann N Y Acad Sci. 1996. PMID: 8624132 Review.
Cited by
-
Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.Front Neurol. 2013 Mar 1;4:17. doi: 10.3389/fneur.2013.00017. eCollection 2013. Front Neurol. 2013. PMID: 23459674 Free PMC article.
-
SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer's disease.Transl Neurodegener. 2020 Sep 21;9(1):37. doi: 10.1186/s40035-020-00214-1. Transl Neurodegener. 2020. PMID: 32951598 Free PMC article.
-
Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.J Neurosci. 2000 Dec 1;20(23):8717-26. doi: 10.1523/JNEUROSCI.20-23-08717.2000. J Neurosci. 2000. PMID: 11102478 Free PMC article.
-
Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo.J Neurosci. 2001 Feb 15;21(4):1327-33. doi: 10.1523/JNEUROSCI.21-04-01327.2001. J Neurosci. 2001. PMID: 11160403 Free PMC article.
-
The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.J Neurosci. 2002 Mar 1;22(5):1858-67. doi: 10.1523/JNEUROSCI.22-05-01858.2002. J Neurosci. 2002. PMID: 11880515 Free PMC article.
References
-
- Aksenova MV, Aksenov MY, Butterfield DA, Carney JM. α-1-antichymotrypsin interaction with Aβ (1–40) inhibits fibril formation but does not affect the peptide toxicity. Neurosci Lett. 1996;211:45–48. - PubMed
-
- Anderton BH, Callahan L, Coleman P, Davies P, Flood D, Jicha GA, Ohm T, Weaver C. Dendritic changes in Alzheimer’s disease and factors that may underlie these changes. Prog Neurobiol. 1998;55:595–609. - PubMed
-
- Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci. 1999;2:271–276. - PubMed
-
- Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. Alzheimer’s disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology. 1998;51:S2–S17. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources